Literature DB >> 6275340

Effects of uridine triphosphate on contractility, cyclic nucleotide levels and membrane potential in the isolated frog ventricle.

J Singh, F W Flitney.   

Abstract

A study has been made of the effects of uridine 5'-triphosphate (UTP) on the isolated frog ventricle. Preparations were superfused with solutions containing different concentrations of UTP, and changes in contractility, cyclic nucleotide levels and membrane potential were measured. UTP produced a long lasting increase in isometric twitch tension, which was unaffected by adrenergic receptor antagonists (propranolol and phentolamine). The levels of adenosine 3',5'-cyclic monophosphate (cyclic AMP) and guanosine 3',5'-cyclic monophosphate (cyclic GMP) were measured at different times during exposure of the ventricle to 10(-4) M UTP. The increase in the force of contraction was found to be accompanied by a rise in intracellular cyclic AMP. Cyclic GMP levels were seen to fall initially, but then to increase later, as both twitch and cyclic AMP started to decline. UTP also produced marked changes in the shape of the action potential; its duration and positive overshoot were both increased. The effects of UTP on twitch tension, cyclic nucleotide levels and action potential parameters were all dose-related. The change in contractility was found to be linearly related to (a) the ratio of the amount of cyclic AMP: cyclic GMP present in the fibres, and (b) to the increase in duration of the action potential. These results suggest that cyclic AMP, cyclic GMP and the availability of Ca2+ may all be involved in mediating the response to UTP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275340     DOI: 10.1007/bf00584573

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  21 in total

1.  Exogenous uridine 5'-triphosphate enhances contractility and stimulates 3',5'-cyclic nucleotide metabolism in the isolated frog ventricle [proceedings].

Authors:  F W Flitney; J Singh
Journal:  J Physiol       Date:  1979-06       Impact factor: 5.182

Review 2.  Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system.

Authors:  A M Katz; M Tada; M A Kirchberger
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

3.  Determination of serum proteins by means of the biuret reaction.

Authors:  A G GORNALL; C J BARDAWILL; M M DAVID
Journal:  J Biol Chem       Date:  1949-02       Impact factor: 5.157

4.  Protein kinase-catalyzed membrane phosphorylation and its possible relationship to the role of calcium in the adrenergic regulation of cardiac contraction.

Authors:  A Wollenberger; H Will
Journal:  Life Sci       Date:  1978 Apr 3-17       Impact factor: 5.037

5.  Inotropic responses of the frog ventricle to dibutyryl cyclic AMP and 8-bromo cyclic GMP and related changes in endogenous cyclic nucleotide levels.

Authors:  J Singh; F W Flitney
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

Review 6.  Calmodulin.

Authors:  C B Klee; T H Crouch; P G Richman
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  Contractures in a superfused frog's ventricle.

Authors:  J F Lamb; J A McGuigan
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

8.  The phosphorylation of troponin I from cardiac muscle.

Authors:  H A Cole; S V Perry
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

9.  The dual effect of calcium on the action potential of the frog's heart.

Authors:  R Niedergerke; R K Orkand
Journal:  J Physiol       Date:  1966-05       Impact factor: 5.182

10.  Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart.

Authors:  P J England
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

View more
  1 in total

1.  Stretch stimulates cyclic nucleotide metabolism in the isolated frog ventricle.

Authors:  J Singh
Journal:  Pflugers Arch       Date:  1982-11-01       Impact factor: 3.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.